Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M G Bock

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
Journal of Medicinal Chemistry|October 1, 1987
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy terminiM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm laborP D Williams, P S Anderson, R G Ball, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Progress in the development of oxytocin antagonists for use in preterm laborD J Pettibone, M Guidotti, C M Harrell, et al.
Journal of Medicinal Chemistry|October 1, 1988
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|December 10, 1993
Nanomolar-affinity, non-peptide oxytocin receptor antagonistsB E Evans, G F Lundell, K F Gilbert, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Journal of Medicinal Chemistry|October 1, 1987
Renin inhibitors. Statine-containing tetrapeptides with varied hydrophobic carboxy terminiM G Bock, R M DiPardo, B E Evans, et al.
Journal of Medicinal Chemistry|March 4, 1994
1-((7,7-Dimethyl-2(S)-(2(S)-amino-4-(methylsulfonyl)butyramido)bicyclo [2.2.1]-heptan-1(S)-yl)methyl)sulfonyl)-4-(2-methylphenyl)piperaz ine (L-368,899): an orally bioavailable, non-peptide oxytocin antagonist with potential utility for managing preterm laborP D Williams, P S Anderson, R G Ball, et al.
Advances in Experimental Medicine and Biology|January 1, 1995
Progress in the development of oxytocin antagonists for use in preterm laborD J Pettibone, M Guidotti, C M Harrell, et al.
Journal of Medicinal Chemistry|October 1, 1988
Renin inhibitors containing hydrophilic groups. Tetrapeptides with enhanced aqueous solubility and nanomolar potencyM G Bock, R M DiPardo, B E Evans, et al.
Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Cyclic imides as potent and selective alpha-1A adrenergic receptor antagonistsR M DiPardo, M A Patane, R C Newton, et al.
Bioorganic & Medicinal Chemistry|September 1, 1994
Selective non-peptide ligands for an accommodating peptide receptor. Imidazobenzodiazepines as potent cholecystokinin type B receptor antagonistsM G Bock, R M DiPardo, R C Newton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1991
Antagonism of oxytocin in rats and pregnant rhesus monkeys by the novel cyclic hexapeptides, L-366,682 and L-366,948B V Clineschmidt, D J Pettibone, D R Reiss, et al.
Journal of Medicinal Chemistry|October 16, 1992
Development of a novel class of cyclic hexapeptide oxytocin antagonists based on a natural productP D Williams, M G Bock, R D Tung, et al.
Journal of Medicinal Chemistry|July 1, 1987
Design of nonpeptidal ligands for a peptide receptor: cholecystokinin antagonistsB E Evans, K E Rittle, M G Bock, et al.
Journal of Medicinal Chemistry|December 10, 1993
Nanomolar-affinity, non-peptide oxytocin receptor antagonistsB E Evans, G F Lundell, K F Gilbert, et al.
Pageof 4